legalities, a drug court treatment provider shares information regarding the progress of a participant in appropriate settings to all drug court team members. Follows all federal confidentiality laws as it pertains to the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 45 Code of Federal Regulations (CFR), Parts 160 and 164, 42 CFR Part 2, RCW chapters 70.02, 70.24, 70.28, 70.96A, 71.05 and 71.34. Follows the confidentiality guidelines in the New Mexico Drug Court Standards, Appendix D (attached). Provides evidenced-based treatment services that include assessment, intake/treatment planning, individual and group therapy sessions, case management, and random, observed drug testing. Provides access and/or referral services to a continuum of care based on ASAM criteria to substance use treatment and other ancillary/complementary treatment services. Provides written treatment status reports for the drug court team before status hearings and as needed (at least monthly) via a secured electronic court database system or email. Provides verbal updates as needed. The nature of the information shared includes, but is not limited to: 1. Assessment results, including level of care recommendations per ASAM assessment and diagnosis; 2. Referrals and status of recommended referrals to outside agencies; 3. Treatment plan goals and objectives; 4. Attendance at scheduled treatment sessions and progress of compliance; 5. Drug testing results; 6. Medication status if applicable; and 7. A discharge summary, when appropriate. Attends weekly pre-court staff meetings, court and policy/procedural meetings. Provides the team with recommendations on participant behavior changes (incentives, sanctions and termination discussions). Is assigned to the drug court for a minimum of 2 years to ensure the stability and continuity of day-to-day operations and strengthen collaborative relationships between the key professionals; Keeps up-to-date with best practices in the treatment field and provides cross-education and training information for the team to make informed choices regarding participants. Maintains integrity of evidenced-based treatment through quality assurance. Contributes to the team’s efforts in community and peer education in the efficacy of Drug Courts, as well as assists with resource acquisition. Can apply certain sanctions between court sessions, with agreement of judge; Receives formal orientation and training administered by previously trained drug court team members (or other experts) within 60 days of joining the team. Continues to present information and/or participate in on-going cross training to remain knowledgeable about
legalities, a drug court treatment provider shares information regarding the progress of a participant in appropriate settings to all drug court team members. Follows all federal confidentiality laws as it pertains to the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 45 Code of Federal Regulations (CFR), Parts 160 and 164, 42 CFR Part 2, RCW chapters 70.02, 70.24, 70.28, 70.96A, 71.05 and 71.34. Follows the confidentiality guidelines in the New Mexico Drug Court Standards, Appendix D (attached). Provides evidenced-based treatment services that include assessment, intake/treatment planning, individual and group therapy sessions, case management, and random, observed drug testing. Provides access and/or referral services to a continuum of care based on ASAM criteria to substance use treatment and other ancillary/complementary treatment services. Provides written treatment status reports for the drug court team before status hearings and as needed (at least monthly) via a secured electronic court database system or email. Provides verbal updates as needed. The nature of the information shared includes, but is not limited to: 1. Assessment results, including level of care recommendations per ASAM assessment and diagnosis; 2. Referrals and status of recommended referrals to outside agencies; 3. Treatment plan goals and objectives; 4. Attendance at scheduled treatment sessions and progress of compliance; 5. Drug testing results; 6. Medication status if applicable; and 7. A discharge summary, when appropriate. Attends weekly pre-court staff meetings, court and policy/procedural meetings. Provides the team with recommendations on participant behavior changes (incentives, sanctions and termination discussions). Is assigned to the drug court for a minimum of 2 years to ensure the stability and continuity of day-to-day operations and strengthen collaborative relationships between the key professionals; Keeps up-to-date with best practices in the treatment field and provides cross-education and training information for the team to make informed choices regarding participants. Maintains integrity of evidenced-based treatment through quality assurance. Contributes to the team’s efforts in community and peer education in the efficacy of Drug Courts, as well as assists with resource acquisition. Can apply certain sanctions between court sessions, with agreement of judge; Receives formal orientation and training administered by previously trained drug court team members (or other experts) within 60 days of joining the team. Continues to present information and/or participate in on-going cross training to remain knowledgeable about
MOU_template_Adult_Drug_Court.docx